Cargando…

Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis

BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiong, Wang, Yurong, Xu, Danyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534355/
https://www.ncbi.nlm.nih.gov/pubmed/36211578
http://dx.doi.org/10.3389/fcvm.2022.929078
_version_ 1784802523432878080
author Wang, Qiong
Wang, Yurong
Xu, Danyan
author_facet Wang, Qiong
Wang, Yurong
Xu, Danyan
author_sort Wang, Qiong
collection PubMed
description BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPOSE: We review the mechanisms of CD4(+) T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines. RESULTS: IL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis. CONCLUSION: The immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development.
format Online
Article
Text
id pubmed-9534355
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95343552022-10-06 Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis Wang, Qiong Wang, Yurong Xu, Danyan Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process. PURPOSE: We review the mechanisms of CD4(+) T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines. RESULTS: IL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis. CONCLUSION: The immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9534355/ /pubmed/36211578 http://dx.doi.org/10.3389/fcvm.2022.929078 Text en Copyright © 2022 Wang, Wang and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wang, Qiong
Wang, Yurong
Xu, Danyan
Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title_full Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title_fullStr Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title_full_unstemmed Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title_short Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
title_sort research progress on th17 and t regulatory cells and their cytokines in regulating atherosclerosis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534355/
https://www.ncbi.nlm.nih.gov/pubmed/36211578
http://dx.doi.org/10.3389/fcvm.2022.929078
work_keys_str_mv AT wangqiong researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis
AT wangyurong researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis
AT xudanyan researchprogressonth17andtregulatorycellsandtheircytokinesinregulatingatherosclerosis